Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22872523 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer
Condition: Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Paclitaxel;   Drug: AMG 706

Indicates status has not been verified in more than two years